| Home | E-Submission | Sitemap | Contact Us |  
J Epilepsy Res > Volume 13(2); 2023 > Article
Lee, Kim, Kang, Lee, Yoo, Kim, and Lee: Aphasic Status Epilepticus Associated with Alzheimer’s Disease: Clinical and Electrographic Characteristics

Abstract

In aphasic status epilepticus (ASE), aphasia is the sole manifestation of seizure in patients with this disorder. Alzheimer’s disease (AD) is one of neurological disorders causing ASE. Herein, we report two cases of ASE associated with AD, and discuss their clinical characteristics. Patient 1 presented Broca’s aphasia, and patient 2 presented global aphasia during the ictal period. Both patients exhibited atypical ictal electroencephalographic (EEG) patterns, which improved after antiepileptic drug administration. ASE was the presenting symptom of AD in patient 1. ASE can develop at any stage of AD. Alterations in clinical symptoms and EEG patterns after treatment with antiepileptic drug are the key to diagnosis. Prompt diagnosis and treatment are critical for preventing further consciousness dysfunction.

Introduction

Aphasic status epilepticus (ASE) is an unusual condition and has clinical characteristics similar to other disorders. However, aphasia is the sole manifestation of seizure in patients with ASE; therefore, other symptoms of status epilepticus, such as consciousness alterations, behavioral and psychiatric symptoms are absent.1,2 Aphasic status epilepticus can emerge from various metabolic or neurological disorders.37 Herein, we report two cases of ASE associated with Alzheimer’s disease (AD) and discuss their clinical characteristics.

Case Report

Patient 1

An 82-year-old right-handed woman developed speech disturbance a week before visiting the Department of Neurology. On neurological examination, the patient was alert and followed one-step verbal commands. However, she could not speak spontaneously. Physical examination revealed no abnormalities. Her medical history, as reported by her husband, revealed that she had experienced a mild decline in memory over the past year; however, she could speak and perform daily activities without any difficulty until a week before this visit. Routine laboratory tests revealed no abnormalities. Electroencephalogram (EEG) revealed an intermittent rhythmic delta activity and quasi-rhythmic fast activity in the frontotemporal area bilaterally, with fluctuating frequency and amplitude (Fig. 1D). The patient was aphasic during the EEG recording period. Brain magnetic resonance imaging (MRI) exhibited diffuse atrophy of the cerebral cortex and hippocampal formation (Fig. 1A, B). The symptoms and EEG abnormalities were absent a day after the administration of valproate (loading dose of 25 mg/kg, and maintenance doses of 6 mg/kg) (Fig. 1E). The patient reported remembering nearly all events during the seizure episodes. Brain single-photon emission computed tomography (SPECT) performed after the control of ASE revealed decreased perfusion in the left frontotemporal area (Fig. 1C). The patient score on the Korean version of the Mini-Mental Status Examination (K-MMSE) was 19 (0/3 in memory registration, 1/5 in attention and calculation, 0/1 in repetition, 4/5 in time orientation, and 3/5 in place orientation), and her Global Deterioration Scale (GDS) score was 4. A detailed neuropsychological test (Seoul Neuropsychological Screening Battery [SNSB]) presented global deterioration, particularly in the domains of memory registration and frontal executive function, which was compatible with AD. The patient follow-up revealed that she has been seizure-free for 5 years after discharge, and her cognitive function gradually has declined to a severe state of dementia, with K-MMSE and GDS scores of 3 and 6, respectively.

Patient 2

An 86-year-old right-handed woman developed sudden unresponsiveness and speech disturbances approximately 12 hours before visiting the Emergency Department. Her son reported that she was not able to understand him. She was diagnosed with AD 5 years before the visit to the clinic and has been irregularly treated with 10 mg of donepezil. The patient did not follow-up in the last 2 years before this visit. The patient scores at diagnosis were 15 on K-MMSE (0/3 in memory registration, 1/5 in attention and calculation, 2/3 in following commands, 0/1 in interlocking pentagon, 0/5 in time orientation, and 4/5 in place orientation) and 4 on GDS. The SNSB exhibited global deterioration, particularly in the domains of memory registration, language, and frontal executive function. On neurological examination, the patient was alert but could not follow verbal commands. However, she could look around and make eye-contact. Focal neurological abnormalities were not found. Laboratory test results revealed no abnormalities. Brain MRI revealed diffuse atrophy of the cerebral cortex and hippocampal formation without acute focal lesions (Fig. 2A, B). The initial EEG exhibited intermittent quasi-rhythmic theta and fast activity were observed bilaterally in the frontotemporal area with fluctuating frequency and amplitude (Fig. 2D). The patient remained aphasic throughout the recording period. The symptoms and EEG abnormalities were absent 8 hours after valproate administration (loading dose of 20 mg/kg, and maintenance doses of 6 mg/kg) (Fig. 2E). Brain SPECT performed after the control of ASE revealed decreased perfusion in the left frontal area (Fig. 2C). The follow-up K-MMSE and GDS scores were 10 and 5, respectively. The patient has been seizure-free for 6 months after discharge.

Discussion

Aphasia is a common neurological manifestation that rarely presents as seizures or status epilepticus; therefore, ASE has rarely been reported, although these reports found some variety in the type of aphasia (Broca’s, Wernicke’s, and global aphasia).811 In this study, patient 1 presented Broca’s aphasia, while patient 2 presented glob al aphasia.
None of the patients exhibited focal cerebral lesions. Focal lesions constitute most instances of ASE; however, nonfocal lesions have also been reported. In nonfocal lesions, metabolic disturbances, such as nonketotic hyperglycemia and aggravated uremia, or drugs, such as cefepime, are reportedly the cause of ASE.46,11 AD is a disorder with nonfocal lesions and can cause ASE.
The causes of seizures in AD are diverse, including extrasynaptic glutamate spillover; tau-induced enhancement of presynaptic glutamate release; reduced axonal and dendritic transport of mitochondria, which regulate neuronal excitability; selective impairment of gamma-aminobutyric acid-ergic interneurons in the hippocampus; altered amounts of voltage-gated ion channels in neurons; alterations in N-methyl-D-aspartate activity; shortened dendrites, which lowers the threshold for action potential generation; impaired cortical input to the reticular thalamic nucleus, which subsequently disinhibits thalamic relay nuclei; and increases in cholinergic tone before the degeneration of cholinergic pathways.12 Subclinical epileptiform activity is often detected in patients with AD, in whom the progression of cognitive decline is faster.12 In patients presenting cognitive fluctuation or rapidly progressive cognitive decline, epileptiform activity and silent seizures should be investigated by EEG.13 Seizures may occur at any stage of AD.14,15 The presenting symptom of AD was ASE in patient 1, while in patient 2 ASE occurred in an advanced stage of AD.
The EEG findings were borderline in both patients, leading to a possible nonconvulsive status epilepticus (NCSE), according to the Salzburg criteria.16 However, the clinical symptoms and electrographic abnormalities responded well to treatment with antiepileptic drugs, characterizing their compatibility with NCSE. Subclinical rhythmic EEG discharges in adults (SREDA) is a rare benign EEG pattern,17 which resembles ictal discharges. Misinterpretation of SREDA may lead to misdiagnosis of epilepsy. The electrographic features of SREDA are characterized as symmetrical, diffuse, rhythmic monomorphic theta waves with sharp contours, usually maximal on the posterior (parietal and posterior temporal) leads.18 The quasi-rhythmic waves observed in the EEG from patient 2 are similar to the patterns of SREDA, with the difference in the fact that the quasi-rhythmic waves are maximal on the frontal leads, showing fluctuations in amplitude and frequency, and are accompanied with fast activity. Moreover, clinical symptoms and EEG abnormalities were absent after the administration of antiepileptic medication.
Valproic acid showed good efficacy and favorable tolerance for status epilepticus in previous studies.19,20 Low dose valproic acid is known to be tolerable in elderly patients.21
Diverse etiologies may lead to ASE, which is usually caused by focal cerebral lesions and less frequently by nonfocal lesions etiologies such as AD. In these cases, ASE may develop in early or advanced stage of AD. The patterns of EEG are diverse, and a typical rhythmic evolutional pattern may not be observed. Alterations in clinical symptoms and EEG patterns after treatment are the key to diagnosis. Prompt diagnosis and treatment are critical to prevent prolonged speech disturbances, which may cause further consciousness dysfunction.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Figure 1
(A, B) Brain magnetic resonance image (MRI), (C) brain single-photon emission tomography (SPECT), (D) initial electroencephalography (EEG), and (E) EEG after administration of valproate. Brain MRI exhibits bilateral hippocampal atrophy ([A] short white arrows), and cortical atrophy ([B] long white arrows). Brain SPECT exhibits hypoperfusion in the left frontal cortex ([C] thick white arrows). Initial EEG (D) exhibits intermittent frontal rhythmic delta activity and quasi-rhythmic fast activity bilaterally (black arrows), which disappears after treatment (E). Fp, frontopolar; F, frontal; C, central; P, parietal; O, occipital; T, temporal.
jer-23009f1.jpg
Figure 2
(A, B) Brain magnetic resonance image (MRI), (C) brain single-photon emission tomography (SPECT), (D) initial electroencephalography (EEG), and (E) EEG after administration of valproate. Brain MRI exhibits bilateral hippocampal atrophy ([A] short white arrows), and cortical atrophy ([B] long white arrows). Brain SPECT exhibits hypoperfusion in the left frontal cortex ([C] thick white arrows). Initial EEG (D) exhibits intermittent frontal quasi-rhythmic theta activity and fast activity bilaterally (black arrows), which disappears after treatment (E). Fp, frontopolar; F, frontal; C, central; P, parietal; O, occipital; T, temporal.
jer-23009f2.jpg

References

1. Wells CR, Labar DR, Solomon GE. Aphasia as the sole manifestation of simple partial status epilepticus. Epilepsia. 1992;33:84–7.
crossref
2. De Pasquet EG, Gaudin ES, Bianchi A, De Mendilaharsu SA. Prolonged and monosymptomatic dysphasic status epilepticus. Neurology. 1976;26:244–7.
crossref pmid
3. Ozkaya G, Kurne A, Unal S, Oğuz KK, Karabudak R, Saygi S. Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of “AIDS-toxoplasmosis complex”. Epilepsy Behav. 2006;9:193–6.
crossref pmid
4. Quintas S, Ródriguez-Carrillo JC, Toledano R, et al. When aphasia is due to aphasic status epilepticus: a diagnostic challenge. Neurol Sci. 2018;39:757–60.
crossref pdf
5. Primavera A, Gianelli MV, Bandini F. Aphasic status epilepticus in multiple sclerosis. Eur Neurol. 1996;36:374–7.
crossref pmid pdf
6. Huang LC, Ruge D, Tsai CL, et al. Isolated aphasic status epilepticus as initial presentation of nonketotic hyperglycemia. Clin EEG Neurosci. 2014;45:126–8.
crossref pmid pdf
7. Armon C, Peterson GW, Liwnicz BH. Alzheimer’s disease underlies some cases of complex partial status epilepticus. J Clin Neurophysiol. 2000;17:511–8.
crossref pmid
8. Grimes DA, Guberman A. De novo aphasic status Epilepticus. Epilepsia. 1997;38:945–9.
crossref pmid
9. Knight RT, Cooper J. Status epilepticus manifesting as reversible Wernicke’s aphasia. Epilepsia. 1986;27:301–4.
crossref pmid
10. Patil B, Oware A. De-novo simple partial status epilepticus presenting as Wernicke’s aphasia. Seizure. 2012;21:219–22.
crossref pmid
11. Qiu JQ, Cui Y, Sun LC, Zhu ZP. Aphasic status epilepticus as the sole symptom of epilepsy: a case report and literature review. Exp Ther Med. 2017;14:3501–6.
crossref pmid pmc
12. Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL. Epileptic activity in Alzheimer’s disease: causes and clinical relevance. Lancet Neurol. 2017;16:311–22.
crossref pmid pmc
13. Vossel KA, Ranasinghe KG, Beagle AJ, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease. Ann Neurol. 2016;80:858–70.
crossref pmid pmc pdf
14. Vossel KA, Beagle AJ, Rabinovici GD, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70:1158–66.
crossref pmid pmc
15. Sarkis RA, Willment KC, Gale SA, Dworetzky BA. Recurrent epileptic auras as a presenting symptom of Alzheimer’s disease. Front Neurol. 2017;8:360
crossref pmid pmc
16. Leitinger M, Beniczky S, Rohracher A, et al. Salzburg consensus criteria for non-convulsive status epilepticus--approach to clinical application. Epilepsy Behav. 2015;49:158–63.
crossref pmid
17. Westmoreland BF, Klass DW. Unusual variants of subclinical rhythmic electrographic discharge of adults (SREDA). Electroencephalogr Clin Neurophysiol. 1997;102:1–4.
crossref pmid
18. Azman Iste F, Tezer Filik FI, Saygi S. SREDA: a rare but confusing benign EEG variant. J Clin Neurophysiol. 2020;37:225–30.
crossref pmid
19. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology. 2005;64:353–5.
crossref pmid
20. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology. 2000;55:722–4.
crossref pmid
21. Stephen LJ. Drug treatment of epilepsy in elderly people: focus on valproic acid. Drugs Aging. 2003;20:141–52.

Editorial Office
KCC Parktown 101-308, Mallijae-ro 185, Jung-Gu, Seoul, Korea
TEL : +82-362-9662   FAX : +82-2-362-9663   E-mail : epilepsy@kes.or.kr

Copyright© Korean Epilepsy Society.              Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers